method
the level of cell types and molecular pathways. Using single-cell mul- used to analyse cellular heterogeneity in complex tissues. To establish
tiomic data, we construct a developmental gene regulatory network an organoid system that enables CRISPR perturbations with single-cell
(GRN) of cerebral organoids and identify ASD-enriched regulatory transcriptomic readout, we used a human embryonic stem cell (hES cell)
hubs connected to the genes that are dysregulated in response to line expressing an enhanced specificity SpCas9 (eCas9), which has subgenetic perturbations. Among the 36 genes, one of the most signifi- stantially reduced off-target effects and is controlled by an upstream
cant changes in cell type composition was identified in the context loxp stop element12 (Fig. 1a). To regulate eCas9 induction, we engiof ARID1B. Specifically, perturbing ARID1B expands ventral radial glia neered a lentiviral vector to deliver 4-hydroxytamoxifen-inducible CRE


374 | Nature | Vol 621 | 14 September 2023

recombinase and a dual single-guide RNA (sgRNA) cassette (Fig. 1a). The dorsal identity, we identified radial glial cells (RGCs; VIM), cycling RGCs
dual sgRNA consists of two sgRNAs targeting the same gene, expressed (ASPM), outer RGCs (oRGCs; HOPX) and intermediate progenitor cells
under the U6 or H1 promoter. The dual gRNA is located within the 3′ (IPCs; EOMES). These progenitors differentiated into excitatory neulong terminal repeat (LTR) and is thus transcribed by RNA polymerase rons with specific layer identities, including layer 5/6 neurons (L5/6;
II to be captured by scRNA-seq assays17. To ensure efficient generation BCL11B), L6 cortical thalamic projection neurons (FOXP2, TLE4)25, L4
of loss-of-function alleles, we determined the editing efficiency of neurons (RORB, UNC5D, NR2F1)26,27 and L2/3 neurons (SATB2). Ventral
each sgRNA pair using a flow cytometry-based gRNA reporter assay radial glial cells (v-RGCs; cell cycling ventral RGCs, ccv-RGCs) differen-
(Fig. 1b and Extended Data Fig. 1a). In this assay, a pre-assembled array tiated into interneuron precursor cells (INPs; DLX2), which generated
of gRNA-targeting sequences fused with TagBFP is used to generate interneurons with lateral ganglionic eminence (LGE) origin (LGE-IN;
3T3 fibroblast reporter cell lines. sgRNA and eCas9 are then delivered MEIS2) or caudal ganglionic eminence (CGE) origin (CGE-IN; NR2F2)28.
into the reporter cell lines by lentiviruses. Successful genome editing Notably, we found a cluster of interneurons expressing MEIS2 and high
causes frameshift mutations, resulting in the loss of blue fluorescent levels of PAX6 (LGE PAX6+ interneurons), a signature that resembles
protein (BFP) fluorescence, which enables the quantitative evaluation mouse olfactory bulb precursors that were recently reported to genof gRNA efficiency (Fig. 1c and Extended Data Fig. 1b,c), although it erate neurons redirected to white matter in primates29. In addition
does not allow for the determination of whether a heterozygous or to neuronal populations, we identified glial cell populations includhomozygous mutation was introduced. Using our reporter assay, we ing astrocytes (S100B, APOE, ALDH1L1) and OPCs (OLIG2, PDGFRA)
selected efficient sgRNA pairs for 36 ASD genes (Extended Data Fig. 1d,e (Fig. 1f,g). RNA velocity analysis30,31 revealed developmental trajectoand Supplementary Table 1). Immunohistochemistry analysis of sev- ries from neural progenitor cells to neuronal populations in both the
eral perturbations in organoids further confirmed the loss of protein dorsal and ventral telencephalons (Extended Data Fig. 6k). Further
products for the majority of selected gRNAs (Extended Data Fig. 2). analysis of our organoid dataset and a primary developing human brain
 We individually cloned sgRNA pairs and pooled them equally to dataset32 revealed cell type-specific expression patterns for several
construct a lentiviral plasmid library (Extended Data Fig. 3a,b). To ASD genes that we targeted in our screen (Extended Data Fig. 6l,m). In
ensure that lentiviral integration frequency was limited to one per cell, summary, our scRNA-seq dataset of 4-month-old cerebral organoids
weused a low infection rate of 2.5% (ref. 18) (Extended Data Fig. 3c–e). recapitulates diverse telencephalic cell types that are present in the
Our analysis indicated homogeneous distribution of the gRNAs in both developing human brain.
the plasmid library and hES cells, which was maintained after the formation of embryoid bodies (Fig. 1d). It is important to note that the
development of human brain tissues exhibits the generation of clones Cell proliferation and depletion phenotypes
with highly variable sizes both in vivo and in vitro12,19. To monitor the Aberrant cell proliferation during brain development has been sugclonal complexity of the founder cells, we introduced a unique clone gested to contribute to ASD pathology33. To test whether ASD genetic
barcode (UCB; 1.4 × 107 combinations) for each dual sgRNA cassette perturbations could affect cell proliferation, we recovered gRNA
to label individual lentiviral integration events (Fig. 1a and Extended information from scRNA-seq complementary DNA libraries as well as
Data Fig. 4a,b). Using this strategy, we obtained an average of 2,770 bulk-extracted genomic DNA from organoid pools of four different
unique clones for each perturbation, which we used to generate mosaic batches (Extended Data Fig. 7a). We observed a heterogenous gRNA repembryoid bodies (Fig. 1e). Altogether, we established a highly efficient resentation in eCas9-induced cells at 4 months. A time course analysis
and controlled pooled screening system with high clonal complexity revealed a deviation from the initial gRNA distribution as early as day
in the organoid. 20 (Extended Data Fig. 7b). When comparing eCas9-induced with unin-
 duced cells from scRNA-seq libraries, we found significantly enriched
 and depleted gRNAs (Fig. 2a,b) (induced cells, n = 14 independent pools
CHOOSE organoids generate diverse cell types of organoids, three batches; uninduced cells, n = 8 independent pools
Cortical abnormalities are a prominent feature of ASD8,20. Many ASD risk of organoids, two batches). Using a FACS-based approach, we further
genes associated with transcriptional regulation and chromatin remod- confirmed the enrichment and depletion phenotypes in individually
elling are crucial for cortical development21,22. Therefore, we aimed perturbed organoids for the four genes (KMT2C, LEO1, ADNP and WAC)
to leverage our methodology to explore loss-of-function phenotypes that showed the largest effect sizes (Extended Data Fig. 8).
for 36 transcriptional control genes with high ASD causal confidence To ensure that the observed cell proliferation phenotypes were not
(Simons Foundation Autism Research Initiative (SFARI) gene score 1)7. driven by clonal effects, we determined the complexity of clones recov-
 We used previously established protocols that reproducibly gener- ered from scRNA-seq libraries. On average, we recovered 125 clones for
ate human telencephalon organoids23,24 (Extended Data Fig. 5a–c). each perturbation and found that the clones were distributed across
eCas9 was induced in 5-day-old embryoid bodies, followed by neural all libraries (Extended Data Fig. 4c,d). Analysing the size of each clone,
induction. Fluorescence-activated cell sorting (FACS)-based analyses we found a mean average cell number per clone of 4.4 (Extended Data
suggest that mutant cells (GFP+/dTomato+) remained at low percent- Fig. 4e,f). These data suggest that cells captured in the CHOOSE screen
ages throughout development, with an average of 21.8% on day 120 came from diverse and relatively small clones, which are crucial for
(Extended Data Fig. 5d–f). It is likely that this could limit the mutant mitigating dominant clonal effects. Bulk analysis of the genomic DNA
cell–cell interactions within the mosaic tissues. Single-cell transcrip- with a higher cell number input (50,000–150,000) revealed high clonal
tome profiling of cerebral organoids at 4 months revealed a large complexity in both eCas9-uninduced and eCas9-induced cells, with
diversity of dorsal and ventral telencephalon cell populations (Fig. 1f,g a homogenous distribution only in uninduced cells (Extended Data
and Extended Data Fig. 6a–j) (14 independent pools of organoids, 3–7 Fig. 4g,h). In conclusion, using a pooled, high-complexity barcoding
organoids each pool, 65 organoids in total, three independent batches). screening system, we successfully identified ASD risk genes that play
We first annotated cell clusters based on control cells (non-targeting essential roles in cell proliferation and survival.
gRNA control) and eCas9-uninduced cells (35,203 cells) (Extended
Data Fig. 6d–f). Cell-type labels for the full CHOOSE dataset (49,754
cells) were then derived through a label transfer. Broadly, we found Cell-type-specific effects of perturbing ASD genes
that perturbed cells adopted cell states resembling those found in Cell type-specific alterations have been observed in patients with ASD
the unperturbed controls (Fig. 1f). We identified progenitor cells with and brain organoid disease models11,34. The large cellular diversity
dorsal (PAX6) or ventral (ASCL1, OLIG2) origins. Among the cells with detected in our system enables us to systematically assess, compare


 Nature | Vol 621 | 14 September 2023 | 375

Article
 a gRNA representation b c
 Dorsal versus ventral Dorsal telen. Ventral telen.
 ADNP *
 ARID1B SETD5
 ASH1L KMT2A
 ASXL3 WAC
 BAZ2B SRCAP
 BCL11A KDM6A
 CHD2 FOXP1
 CHD8
 CHD8
 DEAF1
 CIC SMARCC2
 DDX3X TBR1
 DEAF1 POGZ
 FOXP1 ** MED13L
 ILF2 DDX3X
 IRF2BPL KMT5B
 KAT2B ASH1L


 Perturbed gene
 KDM5B SRSF11
 Perturbed gene


 KDM6A ASXL3
 * ADNP
 KDM6B
 KMT2A LEO1
 KMT2C TCF20
 KMT5B
 ** ILF2
 IRF2BPL
 LEO1 * KDM5B
 MECP2 * BAZ2B
 MED13 MECP2
 MED13L MYT1L
 MYT1L KDM6B
 PHF3 BCL11A
 POGZ CHD2
 SETD5 MED13
 * PHF3
 SMARCC2
 SRCAP KAT2B
 SRSF11 CIC
 TBL1XR1 ARID1B
 TBR1 TBL1XR1
 KMT2C
 TCF20
 WAC * C C C C EN EN PN EN C C P + IN IN IN yte
 RG RG oRG IP /6 /3 Th L4 RG RG IN X6 GE GE roc
 0 0.1 0.2 0.3 0.4 –2 0 2 cc L5 L2 6 C v- cv- A C L t
 L c EP As
 Fraction of cells log2[fold change]
 log2 fold enrichment Cell type LG
 Status CMH test
 Induced t-test FDR FDR < 0.05
 >2 0 <–2
 Uninduced *P < 0.05
 **P < 0.01
 Dorsal Ventral

Fig. 2 | Cell type-specific effects of ASD risk gene perturbations. a, Box b, Bar plot showing fold change of gRNA representation in eCas9-induced
plot showing the representation of gRNAs in eCas9-induced and uninduced versus uninduced cell pools. c, Heat map showing enrichment of gRNAs versus
organoid pools (induced cells, n = 14 independent pools of organoids, three control in dorsal versus ventral telencephalon (telen.) cells (left panel, orange
batches; uninduced cells, n = 8 independent pools of organoids, two batches). to purple) and individual cell types (centre and right panels, red to blue). Colours
The centre lines represent the medians, the box limits show the 25–75% indicate the log odds ratio, and sizes indicate −log10 FDR-corrected P values of a
interquartile ranges and the whiskers indicate 1.5× the interquartile ranges. two-sided CMH test stratified by organoid pool.


and categorize the effects of ASD gene perturbations on cell states. (Extended Data Fig. 11) and increased DLX2+ INPs in KMT2C, MED13,
Using a Cochran–Mantel–Haenszel (CMH) test stratified by library PHF3 and TBL1XR1 perturbations (Extended Data Fig. 12). Furthermore,
replicates, we first assessed the differential abundance of dorsal versus we analysed specific neuronal subpopulations and found that L2/3
ventral telencephalic cells, as well as the abundance of each individual excitatory neurons were more impacted and depleted in the majority of
cell type in each perturbation versus a non-targeting gRNA control (11 perturbations (Fig. 2c). Analysis of interneurons revealed enrichment
independent pools of organoids, two independent batches) (Fig. 2c of both CGE-INs and LGE-INs in three perturbations and enrichment of
and Extended Data Fig. 9). only CGE-INs or LGE-INs in four perturbations. In addition, LGE PAX6+
 For 24 perturbations, we detected significant changes in the ratio of interneurons were depleted by PHF3 perturbation. These data indicate
dorsal to ventral cells (Fig. 2c). Notably, most perturbations (21 of 24) an interneuron subtype-specific response to ASD genetic perturbalowered the dorsal-to-ventral ratio. Perturbation of KMT2C, for exam- tions. Beyond neuronal cell clusters, we found that astrocytes were
ple, led to a strong enrichment of ventral cells. For 23 perturbations, significantly enriched in CIC perturbation.
we detected changes in the abundance of at least one cell type (CMH To assess the consistency of the effects across replicates from diftest, false discovery rate (FDR) < 0.05) (Fig. 2c). On the other hand, six ferent batches, we performed a t-test on individual enrichment and
perturbations specifically targeted one cell type without affecting depletion effects (Extended Data Fig. 10). We observed that most effects
others, including ADNP (L2/3 enrichment), POGZ (RGC enrichment) detected at the single-cell level were also largely consistent across orgaand SETD5 (ccv-RGC enrichment). noids grown from different batches, further supporting the robustness
 Among the progenitors, we identified IPC depletion as a strong, con- and reproducibility of our system.
vergent effect in 12 perturbations (Fig. 2c) (for example, CHD2, KAT2B Collectively, the CHOOSE system allowed us to simultaneously
and KMT2C). Additionally, we observed an enrichment of v-RGCs and/or investigate the effects of multiple ASD genes on cell fate determinaccv-RGCs in 10 perturbations (for example, ARID1B, BCL11A and DEAF1) tion. We found that progenitors, including IPCs and INPs, as well as
and an enrichment of INPs in 10 perturbations (for example, ILF2, MED13 L2/3 excitatory neuronss, were among the most affected cell types.
and TCF20). To validate these phenotypes, we generated individually Furthermore, our data indicate that ASD pathology could emerge as
perturbed organoids for several genes. We performed immunohisto- early as the neural progenitor stage.
chemical analyses of IPCs and INPs at day 60, a stage when organoids
present a radially organized structure including ventricular zone (VZ),
subventricular zone (SVZ) and cortical plate, enabling robust examina- Altered gene expression upon ASD gene perturbation
tion of the progenitors35. Consistent with the screen data, we detected To further assess the molecular changes caused by each perturbation,
significantly decreased EOMES+ IPCs in KMT2C and PHF3 perturbations we performed a differential gene expression analysis, comparing each


376 | Nature | Vol 621 | 14 September 2023

a Dorsal b


 TOMM40
 ATP8B1


 UNC80
 KCNQ5
 KCND3
 ZNF445


 KCNIP4


 ZNF445
 RNF126
 GNGT1


 FOXP2
 EPHA4
 GRIK1


 GRIK2

 GRIK2


 GRIK2


 GRIK1
 GRIK1
 STXBP6


 EXT1
 LINC01830
 2.5 2 GRIA4 CSMD1
 GRIK2 NXPH1 GRIK1
 RBP1
 BRINP3
 0 ETV1 ZIC1
 1


 log2[fold change]
 CHCHD2 KCNIP4


 CHCHD2


 CHCHD2


 CHCHD2


 CHCHD2
 –2.5


 GABRA3


 KCNIP4


 KCNIP4
 CHCHD2


 KCNIP4


 KCNIP4


 KCNIP4
 GRIK2


 GRIK1


 NR2F2
 GRIK1
 CANX
 NKTR


 0
 log2[fold change]


 –5.0 FTSJ3 TCEAL5
 Ventral –1 ATRNL1 PMP2
 DBI


 RUBCN
 TOM1


 SLC8A3
 PCDH15


 PCDH15


 PCDH15
 NEK2


 RPSA
 NPY


 NPY


 GLRX2
 2.5
 –2
 0
 1 2 3 4 5 6 7
 Number of perturbations with DEG


 SRGAP3


 SRGAP3
 –2.5
 WNT5B


 WNT5B


 KCNH7


 NLGN1


 NLGN1


 INTS14
 DDX3X


 DDX3X
 SH2B1


 NR2F2
 GRID2


 GRID2


 GRID2


 SMC3
 NRG1


 NRG1
 Trajectory
 –5.0 Dorsal telen.
 d sysID P=1
 Fisher Ventral telen.
 L 3 2 8 1 L L 5 2 1 1
 NP 1BH1 XL Z2B11A D D CICX3XAF XP1 LF2 PL 2B 5B 6A 6BT2AT2CT5B O1 P2D1313 T1 HF3 GZTD C AP F1 XR R1F20 AC exact test
 AD RIDAS AS BA CL CH CH DD DE FO I F2BKAT DM DM DMKM KM KM LEMECME ED MY P POSE ARCSRC RS L1 TBTC W SFARI P < 10–5
 A B IR K K K M M S TB
 S
 Target gene 0 0.2 0.4 0.6
 log2 (fold enrichment)
 c Gene ontology enrichment
 biological process


 Cell adhesion (e.g., TGFB2, SFRP1, EPHA4)
 Gene ontology


 Cell differentiation (e.g., NRG1, SOX5, EOMES)
 Forebrain development (e.g., DMRTA2, EMX1, POU3F3)
 Axogenesis (e.g., STMN1, NTNG1, MAP2)
 f g
 Cell morphogenesis (e.g., FOXG1, NFIB, ANK3)
 Dorsal telen. Ventral telen.
 0 0.5 1.0 1.5 SATB2
 log2[fold enrichment] BACH2 CREB5
 MEF2C ZNF521
 MEIS2 DACH1
 EOMES
 SOX6 NFIA
 e GRN with ASD-associated TF modules NEUROD6
 OLIG1
 NPCs


 DACH1 ETV1 SOX6 ETV1
 GLI3 RFX4 DACH1
 OLIG1
 SOX6 NPAS3
 CREB5
 ZBTB20 ETV6 RFX4
 STAT3
 Excitatory neurons NFIA
 NFE2L2
 TCF7L2
 TF module


 MEF2C
 MYT1L TOX
 PAX6 PRDM16
 NEUROD2
 ESR2 GLIS3 STAT1
 TSHZ2
 BHLHE22 MEIS2 ZNF536
 SATB2 FOXP2 ARX
 CUX2 RORB
 ZNF521 RORA BCL11B
 NFIB TOX3 EOMES ZFPM2 DACH1
 NFATC2
 BCL11A OLIG1 ZBTB20
 FOXG1 FOXP2
 EOMES
 HES5 RFX4
 MEF2C
 NFIA MEIS2
 Inhibitory neurons


 SFARI gene
 Module enriched
 DLX6 with SFARI genes
 DLX2 0 2 4 6 0 2 4 6
 Enriched and SFARI gene Signed FDR Signed FDR


Fig. 3 | Dysregulated gene expression and regulatory networks caused by TF modules constructed on the basis of their coexpression and interaction
perturbations of ASD risk genes. a, Jitter plots showing DEGs detected in strengths. ASD-associated TF modules are highlighted in yellow (SFARI genes)
dorsal and ventral trajectories from each genetic perturbation. b, Jitter plot and/or black (regulator of SFARI genes). f, Lolliplots show CHOOSE DEG-enriched
shows the frequency of DEGs detected from all perturbations separated by TF modules in dorsal and ventral trajectories. The x axis represents the sign of
dorsal (orange) and ventral (blue) trajectories. Points belonging to the same the log odds ratio multiplied by the −log10 FDR-corrected P value of a two-sided
gene are connected with a grey line. c, Top biological pathways enriched for Fisher exact test (signed −log10 FDR). The dashed lines indicate an FDR of 0.05.
TOP-DEGs (top 30 DEGs per perturbation) identified from all perturbations. g, Circular gene regulatory subnetwork plots show primary and secondary
d, Enrichment test of TOP-DEGs per perturbation in ID (sysID database) or ASD targets of OLIG1 and EOMES. ASD-specific TF modules are highlighted in black
(SFARI database) genes. Two-sided Fisher exact test, P = 3.8 × 10 −7. e, GRN of and yellow as described above. Blue edges indicate repressive connections,
4-month-old cerebral organoids inferred by Pando showing developmental and red edges indicate activating connections. NPC, neural progenitor cell.


perturbation with controls within dorsal and ventral trajectories. We detected DEG is the adhesion molecule gene CSMD1 (Fig. 3a,b), which
detected 2,071 differentially expressed genes (DEGs) across all per- is upregulated by ARID1B, CIC, MED13 and PHF3 perturbations and
turbations (Fig. 3a and Supplementary Data 2). Additionally, we could downregulated by LEO1 and KMT2C perturbations. To ensure a balanced
identify genes dysregulated in both dorsal and ventral populations, impact of differential DEG numbers across all perturbations on downas well as those specifically dysregulated in one population (KMT2C, stream analyses, we selected the top 30 DEGs for each perturbation
LEO1 perturbation) (Extended Data Fig. 13a). We ranked DEGs by detec- (TOP-DEGs) for gene ontology term enrichment analysis. We found that
tion frequency and discovered that many genes were differentially cell adhesion, cell differentiation, forebrain development and axogenexpressed in multiple perturbations (Fig. 3b). Notably, in the dorsal esis were among the most associated biological processes (Fig. 3c and
populations, seven perturbations caused CHCHD2 downregulation Supplementary Data 3). We also observed many perturbation-specific
(Fig. 3a). CHCHD2 encodes a mitochondrial protein, and its downregu- gene ontology terms, many of which confirm previous studies, further
lation has been observed in neurons from the postmortem brains of supporting the power of detecting complex biological phenotypes
patients with ASD34. In the ventral cell populations, the most frequently with the CHOOSE system (Extended Data Fig. 13b and Supplementary


 Nature | Vol 621 | 14 September 2023 | 377

Article
Data 4). Some notable examples include the gene ontology terms ribosome assembly (SETD5 perturbation)36, mitochondrion organization Effects of ARID1B perturbation on v-RGCs
(FOXP1 perturbation)37, lipid homoeostasis (IRF2BPL perturbation)38, Among the 36 genes, we found that ARID1B perturbation caused one
autophagosome maturation (KAT2B perturbation)39 and cilium devel- of the most significant enrichments of v-RGCs (Fig. 2c). Notably, the
opment (MECP2 perturbation)40. OLIG1 regulatory module was also enriched in DEGs caused by ARID1B
 perturbation (Extended Data Fig. 15a). These data motivated us to
 further investigate how v-RGCs are affected by ARID1B perturbation in
ASD-associated regulatory modules the screen. We used Cellrank43 to delineate the developmental trajec-
When combining the TOP-DEGs from all perturbations, we found tories leading to different interneuron subtypes and OPC populations
that they were significantly enriched in risk genes associated with (Fig. 4a). We visualized the terminal fate probabilities for each cell as a
ASD (SFARI database, 1,031 genes; approximately twofold enrich- circular projection, which revealed a distinct differentiation trajectory
ment, Fisher exact test P < 10−5 against genes expressed in 5% of cells from ventral progenitors towards early OPCs (OLIG2, PDGFRA) and a
as background) (Fig. 3d and Supplementary Data 2). Notably, we did branching of INPs (DLX2) into different inhibitory neuronal fates (DLX5)
not observe enrichment in risk genes for other NDDs, such as intel- (Fig. 4b). We found that ARID1B-perturbed cells were strongly enriched
lectual disability (ID; sysID database, 936 primary ID genes) (Fig. 3d), in the OPC trajectory and had a higher percentage of OLIG2+ v-RGCs
suggesting that certain biological processes and regulatory programs (Fig. 4c,d). This is an interesting finding given that OLIG2 is known
might be specifically relevant to ASD-associated gene perturbations. to regulate progenitor self-renewal at earlier developmental stages
To explore these potential gene regulatory ‘hubs’, we first generated and is a master regulator for oligodendrocyte lineage specification
single-cell multiome data, including single-cell transcriptome and in the ventral telencephalon44,45. We then analysed the fate transition
chromatin accessibility modalities, from 4-month-old cerebral orga- probabilities of ventral progenitors and found that ARID1B-perturbed
noids (Extended Data Fig. 14a–g). Using Pando41, we harnessed these v-RGCs have significantly higher transition probabilities towards early
multimodal measurements to infer a GRN of the developing telencepha- OPCs than neuronal fates (Fig. 4e).
lon and extract sets of genes regulated by each transcription factor Loss-of-function mutations in ARID1B have been shown to cause ID
(TF) module, as well as positive and negative regulatory interactions and ASD7,46. To confirm whether our findings are relevant to human disbetween the TFs (Extended Data Fig. 14h,i and Supplementary Data 5). orders, we recruited two patients with heterozygous ARID1B mutations.
We visualized this GRN on the level of TFs using a uniform manifold Patient 1 harbours a nucleotide duplication (c.2201dupG), resulting
approximation and projection (UMAP) embedding42, which revealed in an early STOP codon. Patient 2 carries a microdeletion (6q25.3del)
distinct TF groups active in neural progenitor cells (PAX6, GLI3), inhibi- that includes exon 8 and the downstream region of the ARID1B locus
tory neurons (DLX2, DLX6) and excitatory neurons (NEUROD2, NFIB, (Extended Data Fig. 15b,c). We established iPS cell lines from both
SATB2) as well as regulatory interactions between the TFs (Fig. 3e). patients and a mutation-corrected cell line for patient 1 as an isogenic
 To test whether regulatory subnetworks indeed exist at which ASD control. To investigate the behaviour of v-RGCs, we used a previously
risk genes accumulate, we tested all TF modules for enrichment with published protocol that uses smoothened agonist (SAG) and inhibitor
SFARI genes. We found significant enrichment for a set of 40 TFs of Wnt production-2 (IWP2) to specifically guide organoids to develop
(adjusted Fisher test P < 0.01, more than twofold enrichment; for exam- ventral telencephalic tissue47,48. In line with our previous findings, we
ple, EOMES, OLIG1, DLX2) (Extended Data Fig. 14j), among which 14 TFs observed considerably increased OLIG2+, DLX2+ and DLX2+OLIG2+ cells
were encoded by ASD risk genes (for example, NFIA, BCL11A, MEF2C) in 40-day-old organoids from both patients compared with control
(Fig. 3e). All TF regulatory modules enriched in SFARI genes together organoids (Fig. 4f,g). To further explore the potential consequences
form an ASD-associated sub-GRN (Supplementary Data 6). of such defects in patients, we analysed the prenatal brain structure of
 Next, we assessed the transcriptomic effect of ASD genetic pertur- patient 2 at two gestation stages (gestational weeks (GW) 22 and GW31)
bations in the context of the inferred GRN. We performed enrichment by intrauterine super-resolution magnetic resonance imaging (MRI).
tests (Fisher exact test) on perturbation-induced TOP-DEGs (CHOOSE Three-dimensional reconstruction of the ganglionic eminence (GE),
DEGs) from dorsal and ventral telencephalic cells separately. We found the source of ventral telencephalon progenitors, and normalization to
that, similar to ASD risk genes, CHOOSE DEGs were enriched in specific cortical and total brain volume revealed an enlarged GE compared with
TF modules (Fig. 3f and Supplementary Data 7). In the ventral telence- multiple age-matched controls at both examined developmental stages
phalic cells, CREB5, MEIS2, NFIA and OLIG1 were most strongly affected, (Fig. 4h and Extended Data Fig. 15d–h), which could be partially due
whereas dorsal telencephalon-specific DEGs were strongly enriched to an increase in ventral progenitors. Taken together, the enrichment
in SATB2, BACH2, MEF2C and EOMES modules. Notably, some of the of v-RGCs and ccv-RGCs (Fig. 2a), the higher transition probability of
ASD-associated TF modules were among the most strongly enriched in v-RGCs to early OPCs, and the increased proportion of OLIG2+ cells in
CHOOSE DEGs, supporting their role in ASD-associated gene dysregula- our screen and in organoids generated from two patient iPS cell lines all
tion (Fig. 3f). We finally present gene regulatory subnetworks of OLIG1 suggest that ARID1B perturbation leads to abnormal ventral progenitor
and EOMES, which are both enriched in ASD risk genes and strongly expansion and aberrant cell fate specification (Fig. 4i). The enlarged
affected by ASD genetic perturbations (Fig. 3g). Oligodendrocyte tran- volume of GE in the patient with an ARID1B mutation is consistent with
scription factor 1 (OLIG1) is preferentially expressed in the ventral tel- these observations.
encephalon and is a key regulator for interneuron and oligodendrocyte
lineages. Eomesodermin (EOMES) is a key TF for the fate specification of
IPCs in the dorsal telencephalon. The enrichment of OLIG1 and EOMES Discussion
regulomes suggests potentially vulnerable cell fate specification-related We have developed the CHOOSE system to characterize loss-of-function
regulatory networks upon ASD genetic perturbations. phenotypes of high-risk ASD genes across dozens of cell types spanning
 Thus, we have characterized gene expression changes for each early brain developmental stages in cerebral organoids. By employing
genetic perturbation in both dorsal and ventral telencephalon and a pooled CRISPR screening system in conjunction with validation, our
uncovered molecular programs shared between different perturba- study provides a developmental and cell type-specific phenotypic datations. Leveraging GRN inference from multiomic data, we further base for ASD gene loss-of-function research. IPCs, transit-amplifying
identified ASD-associated TF modules during cortical development dorsal progenitors that generate neurons for all cortical layers and conand critical regulatory hubs underlying the detected gene expression tribute to the evolutionary expansion of the human cortex49,50, appeared
changes. to be particularly susceptible to ASD genetic perturbations. Among the


378 | Nature | Vol 621 | 14 September 2023

a CGE IN
 b DLX2 DLX5 c Depleted


 Enriched


 LGE_PAX6 LGE
 IN IN
 OLIG2 PDGFRA d e P < 10–5


 OPC transition probability
 1.00
 1.00 OLIG2 /DLX2
 + –


 Proportion cells
 0.75 0.75
 OLIG2+/DLX2+
 0.50 0.50
 OPC 0.25 OLIG2–/DLX2+
 0.25
 Expression 0
 v-RGCs INPs LGE INs OLIG2–/DLX2– 0


 AR o l
 1B
 OPCs CGE INs LGE_PAX6 INs 0 Maximum


 tr
 ID
 on


 ID l
 1B
 AR ntro
 C


 o
 C
 f Control (c.2201dupG repair) ARID1B+/– (c.2201dupG) ARID1B+/– (6q25.3del)
 h


 Control
 Hoechst GE
 DLX2
 OLIG2

 GW22 + 4


 (6q25.3del)
 DLX2

 GE


 +/–
 ARID1B
 OLIG2 GW23 + 0


 g *** *** i WT Ventral Lineage-specified
 15 *** *** ***
 progenitors progenitors

 *** Early
 15 10 OLIG2
 Number of OLIG2+ cells


 OLIG2+ OPC
 per 103 μm2 area


 10
 OLIG2+, DLX2 INP
 DLX2+ OLIG2+


 10 DLX2+
 DLX2+


 5
 5 ARID1B perturbation
 5
 OLIG2 Early
 OLIG2+ OPC
 0 0
 0
 OLIG2+, DLX2 INP
 DLX2+
 Control (c.2201dupG repair) ARID1B+/– (c.2201dupG) ARID1B+/– (6q25.3del)


Fig. 4 | Perturbation of ARID1B increases the transition of v-RGCs to early OPCs (OLIG2) and INPs (DLX2) of day 40 ventralized brain organoids derived
OPCs. a, Circular projection of terminal fate probabilities shows ventral from control (c.220dupG repair) and two ARID1B patient iPS cells. Scale bar,
telencephalon differentiation trajectories. b, Trajectory branches defined by 200 μm. g, Violin plots (all data points and median values) show numbers of
gene expressions of DLX2 (INP), DLX5 (IN), OLIG2 (early OPC) and PDGFRA (late cells positive for OLIG2 and/or DLX2. Control, n = 108 areas from 13 organoids,
OPC). c, Differential density of cells with ARID1B perturbation versus control. four batches; ARID1B+/− (c.2201dupG), n = 104 areas from 15 organoids, four
d, Bar graph shows cells within the v-RGCs that are positive for DLX2 (68.6 versus batches; ARID1B+/− (6q25.3del), n = 94 areas from 15 organoids, three batches.
81.5%), OLIG2 (19.6 versus 36.2%) and both (9.8 versus 30.6%) in control versus One-way analysis of variance (ANOVA) post hoc Tukey test; ***P < 0.001.
ARID1B perturbation. e, Box plots showing transition probabilities of control h, Prenatal magnetic resonance imaging scan and 3D reconstruction of LGE and
(n = 51) and ARID1B-perturbed (n = 46) ventral progenitor cells towards OPCs. CGE (marked as GE) from age-matched controls and a patient with an ARID1B
The centre lines represent the medians, the box limits show the 25–75% mutation showing enlarged GE in the patient (quantified in Extended Data
interquartile ranges and the whiskers indicate 1.5× the interquartile ranges. Fig. 10). Scale bar, 1 cm. i, Diagram showing ARID1B perturbation-induced
Two-sided Wilcoxon test P value = 7.7 × 10 −8. f, Immunohistochemistry for early cellular responses of ventral progenitors. WT, wild type.


ventral telencephalon cells, we have identified strong enrichment of constructed a telencephalon developmental trajectories-based GRN
v-RGCs, ccv-RGCs and INPs, which are progenitors that differentiate and identified ASD-associated regulatory modules in dorsal and veninto interneurons and oligodendrocytes44,51. Furthermore, our find- tral cell populations. The OLIG1 module is particularly interesting as
ings indicate that L2/3 excitatory neurons are more vulnerable than many of its downstream targets are ASD risk genes. This module was
other neuronal populations to ASD perturbations. This aligns with the previously identified as crucial for oligodendrocyte differentiation in
observation that ASD risk gene coexpression networks are enriched in the developing human cortex22, highlighting the involvement of the
upper-layer neurons during development and that these neurons are oligodendrocytes in ASD pathophysiology.
preferentially affected in ASD patients6,34. In our screen, we assessed The combination of high-content perturbation screening and vali-
19 ASD genes known to be involved in epigenetic regulation. Despite dation in a patient-specific context exemplifies the effectiveness of
their broad role in cell differentiation, perturbations of these genes employing organoid systems to study NDDs. We discovered that loss
impacted specific cell types and biological processes during brain of ARID1B leads to increased transition of ventral progenitors to early
development. DEG and gene ontology enrichment analyses revealed OPCs. Importantly, perturbations of three BAF complex members
both common and distinct molecular processes impaired in differ- (ARID1B, BCL11A and SMARRC2) all lead to enrichment of v-RGCs,
ent perturbations, suggesting that both convergent and divergent indicating the critical role of the BAF complex in regulating ventral
mechanisms contribute to ASD pathophysiology. Furthermore, we telencephalon cell fate specification. Given the cell type-specific


 Nature | Vol 621 | 14 September 2023 | 379

Article
expression of each BAF subunit and their involvement in NDDs52, it 22. Trevino, A. E. et al. Chromatin and gene-regulatory dynamics of the developing human
 cerebral cortex at single-cell resolution. Cell 184, 5053–5069.e23 (2021).
would be interesting to investigate how ARID1B or other subunits regu- 23. Lancaster, M. A. et al. Guided self-organization and cortical plate formation in human
late oligodendrocyte and interneuron specification, as well as their brain organoids. Nat. Biotechnol. 35, 659–666 (2017).
contribution to NDDs. 24. Eichmüller, O. L. et al. Amplification of human interneuron progenitors promotes brain
 tumors and neurological defects. Science 375, eabf5546 (2022).
 Our study has limitations. First, our system lacks certain brain cell 25. Tsyporin, J. et al. Transcriptional repression by FEZF2 restricts alternative identities of
types, such as microglia, and does not include interneurons derived cortical projection neurons. Cell Rep. 35, 109269–109269 (2021).
from the medial ganglionic eminence. Future studies should explore 26. Zhong, Y. et al. Identification of the genes that are expressed in the upper layers of the
 neocortex. Cereb. Cortex 14, 1144–1152 (2004).
the impact of ASD gene alterations on these cell types or use a system 27. Oishi, K. et al. Identity of neocortical layer 4 neurons is specified through correct positioning
that better resembles in vivo cell-type complexity. Second, we do not into the cortex. eLife 5, e10907 (2016).
know whether perturbed cells are heterozygous or homozygous for 28. Shi, Y. et al. Mouse and human share conserved transcriptional programs for interneuron
 development. Science 374, eabj6641 (2021).
each mutant. It would be interesting to generate precisely edited cells 29. Schmitz, M. T. et al. The development and evolution of inhibitory neurons in primate
to compare mutation-specific phenotypes. Additionally, the effects of cerebrum. Nature 603, 871–877 (2022).
perturbations of ASD risk genes on cell-type abundances can sometimes 30. Manno, G. L. et al. RNA velocity of single cells. Nature 560, 494–498 (2018).
 31. Bergen, V., Lange, M., Peidli, S., Wolf, F. A. & Theis, F. J. Generalizing RNA velocity to
be transient11,53, and therefore certain abnormalities during develop- transient cell states through dynamical modeling. Nat. Biotechnol. 38, 1408–1414 (2020).
ment may not be captured. 32. Braun, E. et al. Comprehensive cell atlas of the first-trimester developing human brain.
 The ability to determine cell type-specific contributions to genetic Preprint at bioRxiv https://doi.org/10.1101/2022.10.24.513487 (2022).
 33. Courchesne, E. et al. The ASD Living Biology: from cell proliferation to clinical phenotype.
disorders in a systematic, scalable and efficient manner will greatly Mol. Psychiatr. 24, 88–107 (2019).
enhance our understanding of disease mechanisms. As the CHOOSE 34. Velmeshev, D. et al. Single-cell genomics identifies cell type–specific molecular changes
system provides a robust, precisely controlled screening strategy, we in autism. Science 364, 685–689 (2019).
 35. Qian, X. et al. Sliced human cortical organoids for modeling distinct cortical layer formation.
anticipate that it will be widely applied beyond brain organoids to study Cell Stem Cell 26, 766–781.e9 (2020).
disease-associated genes. 36. Nakagawa, T. et al. The autism-related protein SETD5 controls neural cell proliferation
 through epigenetic regulation of rDNA expression. iScience 23, 101030 (2020).
 37. Wang, J. et al. Mitochondrial dysfunction and oxidative stress contribute to cognitive and
 motor impairment in FOXP1 syndrome. Proc. Natl Acad. Sci. USA 119, e2112852119 (2022).
Online content 38. Chen, H.-H. et al. IRF2BP2 reduces macrophage inflammation and susceptibility to
 atherosclerosis. Circ. Res. 117, 671–683 (2015).
Any methods, additional references, Nature Portfolio reporting summa-
 39. Jia, Y.-L. et al. P300/CBP-associated factor (PCAF) inhibits the growth of hepatocellular
ries, source data, extended data, supplementary information, acknowl- carcinoma by promoting cell autophagy. Cell Death Dis. 7, e2400–e2400 (2016).
edgements, peer review information; details of author contributions 40. Frasca, A. et al. MECP2 mutations affect ciliogenesis: a novel perspective for Rett syndrome
 and related disorders. EMBO Mol. Med. 12, e10270 (2020).
and competing interests; and statements of data and code availability
 41. Fleck, J.S., Jansen, S.M.J., Wollny, D. et al. Inferring and perturbing cell fate regulomes in
are available at https://doi.org/10.1038/s41586-023-06473-y. human brain organoids. Nature https://doi.org/10.1038/s41586-022-05279-8 (2022).
 42. Becht, E. et al. Dimensionality reduction for visualizing single-cell data using UMAP. Nat.
 Biotechnol. 37, 38–44 (2019).
1. Hu, W. F., Chahrour, M. H. & Walsh, C. A. The diverse genetic landscape of 43. Lange, M. et al. CellRank for directed single-cell fate mapping. Nat. Methods 19, 159–170
 neurodevelopmental disorders. Genom. Hum. Genet. 15, 195–213 (2014). (2022).
2. Klingler, E., Francis, F., Jabaudon, D. & Cappello, S. Mapping the molecular and cellular 44. Petryniak, M. A., Potter, G. B., Rowitch, D. H. & Rubenstein, J. L. R. Dlx1 and Dlx2 control
 complexity of cortical malformations. Science 371, eaba4517 (2021). neuronal versus oligodendroglial cell fate acquisition in the developing forebrain. Neuron
3. Libé-Philippot, B. & Vanderhaeghen, P. Cellular and molecular mechanisms linking 55, 417–433 (2007).
 human cortical development and evolution. Annu. Rev. Genet. 55, 555–581 (2021). 45. Sun, Y. et al. Phosphorylation state of Olig2 regulates proliferation of neural progenitors.
4. Lui, J. H., Hansen, D. V. & Kriegstein, A. R. Development and evolution of the human Neuron 69, 906–917 (2011).
 neocortex. Cell 146, 18–36 (2011). 46. Moffat, J. J., Smith, A. L., Jung, E.-M., Ka, M. & Kim, W.-Y. Neurobiology of ARID1B
5. Willsey, A. J. et al. Coexpression networks implicate human midfetal deep cortical haploinsufficiency related to neurodevelopmental and psychiatric disorders. Mol.
 projection neurons in the pathogenesis of autism. Cell 155, 997–1007 (2013). Psychiatr. 27, 476–489 (2022).
6. Parikshak, N. N. et al. Integrative functional genomic analyses implicate specific molecular 47. Bagley, J. A., Reumann, D., Bian, S., Lévi-Strauss, J. & Knoblich, J. A. Fused cerebral
 pathways and circuits in autism. Cell 155, 1008–1021 (2013). organoids model interactions between brain regions. Nat. Methods 14, 743–751 (2017).
7. Satterstrom, F. K. et al. Large-scale exome sequencing study implicates both developmental 48. Bajaj, S. et al. Neurotransmitter signaling regulates distinct phases of multimodal human
 and functional changes in the neurobiology of autism. Cell 180, 568–584.e23 (2020). interneuron migration. EMBO J. 40, e108714 (2021).
8. Torre-Ubieta, L., de la Won, H., Stein, J. L. & Geschwind, D. H. Advancing the understanding 49. Martínez-Cerdeño, V., Noctor, S. C. & Kriegstein, A. R. The role of intermediate progenitor
 of autism disease mechanisms through genetics. Nat. Med. 22, 345–361 (2016). cells in the evolutionary expansion of the cerebral cortex. Cereb. Cortex 16, i152–i161
9. Lancaster, M. A. et al. Cerebral organoids model human brain development and (2006).
 microcephaly. Nature 501, 373–379 (2013). 50. Pebworth, M.-P., Ross, J., Andrews, M., Bhaduri, A. & Kriegstein, A. R. Human intermediate
10. Mariani, J. et al. FOXG1-dependent dysregulation of GABA/glutamate neuron differentiation progenitor diversity during cortical development. Proc. Natl Acad. Sci. USA 118,
 in autism spectrum disorders. Cell 162, 375–390 (2015). e2019415118 (2021).
11. Paulsen, B. et al. Autism genes converge on asynchronous development of shared neuron 51. Kessaris, N. et al. Competing waves of oligodendrocytes in the forebrain and postnatal
 classes. Nature 602, 268–273 (2022). elimination of an embryonic lineage. Nat. Neurosci. 9, 173–179 (2006).
12. Esk, C. et al. A human tissue screen identifies a regulator of ER secretion as a brain-size 52. Sokpor, G., Xie, Y., Rosenbusch, J. & Tuoc, T. Chromatin remodeling BAF (SWI/SNF)
 determinant. Science 370, 935–941 (2020). complexes in neural development and disorders. Front. Mol. Neurosci. 10, 243 (2017).
13. Michels, B. E. et al. Pooled in vitro and in vivo CRISPR-Cas9 screening identifies tumor 53. Villa, C. E. et al. CHD8 haploinsufficiency links autism to transient alterations in excitatory
 suppressors in human colon organoids. Cell Stem Cell 26, 782–792.e7 (2020). and inhibitory trajectories. Cell Rep. 39, 110615 (2022).
14. Dixit, A. et al. Perturb-seq: dissecting molecular circuits with scalable single-cell RNA
 profiling of pooled genetic screens. Cell 167, 1853–1866.e17 (2016).
 Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in
15. Jaitin, D. A. et al. Dissecting immune circuits by linking CRISPR-pooled screens with
 published maps and institutional affiliations.
 single-cell RNA-seq. Cell 167, 1883–1896.e15 (2016).
16. Adamson, B. et al. A multiplexed single-cell CRISPR screening platform enables systematic
 dissection of the unfolded protein response. Cell 167, 1867–1882.e21 (2016). Open Access This article is licensed under a Creative Commons Attribution
17. Datlinger, P. et al. Pooled CRISPR screening with single-cell transcriptome read-out. Nat. 4.0 International License, which permits use, sharing, adaptation, distribution
 Methods 14, 297–301 (2017). and reproduction in any medium or format, as long as you give appropriate
18. Doench, J. G. Am I ready for CRISPR? A user’s guide to genetic screens. Nat. Rev. Genet. credit to the original author(s) and the source, provide a link to the Creative Commons licence,
 19, 67–80 (2018). and indicate if changes were made. The images or other third party material in this article are
19. Bizzotto, S. et al. Landmarks of human embryonic development inscribed in somatic included in the article’s Creative Commons licence, unless indicated otherwise in a credit line
 mutations. Science 371, 1249–1253 (2021). to the material. If material is not included in the article’s Creative Commons licence and your
20. Chen, J. A., Peñagarikano, O., Belgard, T. G., Swarup, V. & Geschwind, D. H. The emerging intended use is not permitted by statutory regulation or exceeds the permitted use, you will
 picture of autism spectrum disorder: genetics and pathology. Pathology Mech. Dis. 10, need to obtain permission directly from the copyright holder. To view a copy of this licence,
 111–144 (2015). visit http://creativecommons.org/licenses/by/4.0/.
21. Study, T. D. et al. Synaptic, transcriptional, and chromatin genes disrupted in autism.
 Nature 515, 209–215 (2014). © The Author(s) 2023, corrected publication 2023


380 | Nature | Vol 621 | 14 September 2023

Methods using HEK293 cells to produce lentivirus. The reporter 3T3 cell lines
 generated above were cultured in six-well plates and infected with
Stem cell and cerebral organoid culture conditions lentivirus containing dual sgRNA cassette targeting each gene individu-
Feeder-free hES cells or iPS cells were cultured on hES cell-qualified ally. BFP fluorescence was measured at 7, 14 and 20 days postinfection.
Matrigel (Corning, catalogue no. 354277)-coated plates with Essential8 Fluorescent changes at 20 days postinfection were used to evaluate
stem cell medium supplemented with bovine serum albumin (BSA). the gRNA editing efficiency. In total, 98 dual sgRNA cassettes were
H9 embryonic stem cells were obtained from WiCell. Cells were main- tested for 36 genes.
tained in a 5% CO2 incubator at 37 °C. All cell lines were authenticated
using a short tandem repeat assay, tested for genomic integrity using Generation of barcoded CHOOSE lentivirus, hES cell infection
single-nucleotide polymorphism (SNP) array genotyping and routinely and embryoid body generation. The CHOOSE lentiviral vector
tested negative for mycoplasma. was constructed based on a previously published lentiviral vec-
 Cerebral organoids were generated using a previously published tor that carries a CAG driving ERT2-Cre-ERT2-P2A-EGFP-P2A-puro
protocol with modifications23. In brief, cells were cultured to 70–80% cassette12. A multicloning site including NheI and SgsI recognition
confluent, and 16,000 live cells in 150 μl Essential8 medium supple- sequences was introduced to the 3′ LTR of the lentivirus backbone
mented with Revitacell (ThermoFisher, catalogue no. A2644501) were according to the CROP-seq vector design17. Then, the original U6
added to each well of a U-bottom ultralow attachment 96-well plate sgRNA expression cassette was removed; instead, the dual sgRNA
(Corning, catalogue no. CLS3473) to form embryoid bodies. For eCas9 (U6-sgRNA1-H1-sgRNA2) cassette was introduced to the 3′ LTR cloning
induction, 4-hydroxytamoxifen (Sigma-Aldrich, catalogue no. H7904) site. To generate a barcoded library, the following primers were used
was added on day 5 at a concentration of 0.3 μg ml−1. Neural induction to individually amplify (8–10 cycles, monitored using a quantitative
was started on day 6. Embryoid bodies were embedded in Matrigel polymerase chain reaction (qPCR) machine, stopped when reaching
(Corning, catalogue no. 3524234) at day 11 or 12 based on morphology to logarithmic phase) each dual sgRNA cassette from the lentiviral
check. CHIR99021 (Merck, catalogue no. 361571) at 3 μM was added construct used in the reporter assay while introducing a 15 base pair
from day 13 to day 16, and medium was switched to improved differ- barcode.
entiation medium supplemented with B27 minus vitamin A (IDM-A) at FW primer: 5′-tcgaccgctagcagggcctatttcccatga-3′.
day 14. On day 25, medium was switched to improved differentiation RV primer: 5′-cagtagggcgcgccNVDNHBNVDNHBNVDccggcg
medium supplemented with B27 plus vitamin A (IDM+A); 1% dissolved aaccatgatcaaa-3′.
Matrigel was added to the medium from day 40 to day 90. From day Equal molar amounts of amplicons for the ASD library (36 paired
60 to day 70, medium was gradually switched to Brainphys neuronal sgRNAs targeting ASD genes) or control library (a paired non-targeting
medium (Stemcell Technologies, catalogue no. 05790) and supple- control gRNA) were pooled. Amplicons and lentiviral backbone were
mented with brain-derived neurotrophic factor (BDNF) (20 ng ml−1; then digested with FastDigest NheI (ThermoFisher, catalogue no.
Stemcell Technologies, catalogue no. 78005.3), glial cell line-derived FD0973) and FastDigest SgsI (ThermoFisher, catalogue no. FD1894)
neurotrophic factor (GDNF) (20 mg ml−1; Stemcell Technologies, cata- and gel purified. Ligation was performed using T4 DNA ligase (Therlogue no. 78058.3) and bucladesine sodium (1 mM; MedChemExpress, moFisher, catalogue no. EL0011) and cleaned up by phenol-chloroform
catalogue no. HY-B0764)24. For ventralized organoids, we followed a extraction. In total, 90 ng of ASD library plasmids and 30 ng of control
previously published protocol47. Embryoid bodies were not embed- library plasmids were used for electroporation of MegaX DH10B T1R
ded, and patterning factors, including 100 nm SAG (Merck-Millipore, Electrocomp Cells (ThermoFisher, catalogue no. C640003) followcatalogue no. US1566660) and 2.5 μM IWP2 (Sigma-Aldrich, catalogue ing the manufacturer’s guide. Bacteria were plated on lithium borate
no. IO536), were added from day 5 to day 11. medium plates containing ampicillin. Dilutions were performed to
 calculate the complexity; 2.6 × 107 colonies were obtained for the ASD
CHOOSE screen library, and 0.5 × 107 colonies were obtained for the control library.
sgRNA selection and cloning. The top four sgRNAs were first se- Lentiviruses were packaged using HEK293T cells, and infection of
lected on the basis of predictions using multilayered Vienna Bioac- hES cells was performed as before12. Infection rate was controlled to
tivity CRISPR (VBC) score54 and then subjected to the reporter assay be lower than 5% to prevent multiple infections18; 6.6 × 105 ASD library
(below) to test editing efficiency. sgRNAs were cloned into the gRNA cells and 2.3 × 105 control library cells positive for GFP were sorted
reporter assay lentivirus construct (containing the dual sgRNA cas- by flow cytometry. Cells were recovered and passaged two times in
sette: U6-sgRNA1-H1-sgRNA2) using the GeCKO cloning protocol55. 10 cm dishes to maintain maximum complexity. Cells were mixed with
The two sgRNAs were cloned using type IIS class restriction enzymes a ratio of 96:4 (ASD:control) and then used to make embryoid bod-
FastDigest BpiI (ThermoFisher, catalogue no. FD1014) and Esp3I (Ther- ies. For individual gene validations, lentivirus carrying a dual gRNA
moFisher, catalogue no. FD0454) separately and verified using Sanger cassette only targeting one gene was packaged and used to infect the
sequencing. All gRNAs used for this study can be found in Supplemen- eCas9-inducible cell line. Cells were then collected by FACS and used to
tary Table 1. make embryoid bodies. Organoids were cultured using the conditions
 described above.
sgRNA reporter assay. A construct containing dTomato-2A-gRNA
target array-TagBFP under the RSV promoter was assembled using Cerebral organoid tissue dissociation, FACS and scRNA-seq. For
Gibson assembly. The construct was packaged into retrovirus us- each library, three to seven organoids at 4 months were pooled, washed
ing the Platinum-E retroviral packaging cell line via the calcium twice in Dulbecco’s phosphate-buffered saline (DPBS)−/− and dissociated
phosphate-based transfection method. Virus-containing supernatant using the gentleMACS dissociator in trypsin–accutase (1×) solution with
(Dulbecco’s modified Eagle’s medium (DMEM), 10% fetal bovine serum TURBO DNase (2 μl ml−1; ThermoFisher, catalogue no. AM2238). After
(FBS), 2 mM l-glutamine, 100 U ml−1 penicillin and 0.1 mg ml−1 strepto- dissociation, DPBS−/− supplemented with 10% FBS (DPBS–10% FBS) was
mycin) was collected for up to 72 h, filtered through a 0.45-μm filter gradually added to stop the reaction. Samples were then centrifuged
and then stored on ice. Retroviruses were then used to infect NIH-3T3 at 400g for 5 min at 4 °C, and the supernatant was aspirated without
cells, and dTomato-positive cells were sorted using flow cytometry touching the pellet. The pellet was then resuspended in an additional
into single cells to establish reporter cell lines. To deliver sgRNAs, the 1–2 ml of DPBS–10% FBS and then, filtered through a 70 μm strainer and
lentiviral construct containing the dual gRNA cassette and the spleen FACS tubes. Cells were then stained with viability dye DRAQ7 (Biostatus;
focus-forming virus (SFFV) promoter driving eCas9 were packaged DR70250, 0.3 mM). Target live cells were sorted with a BD FACSAria III

Article
on Alexa 700 filter with low pressure (100 μm nozzle) and collected in
DPBS–10% FBS at 4 °C. Cells were then centrifuged and resuspended in Preprocessing of single-cell transcriptomics data
DPBS–10% FBS to achieve a target concentration of 450–1,000 cells per We first aligned reads to the above defined custom genomic reference
microliter. Samples with more than 85% viability were processed. For with Cell Ranger 6.0 (10x Genomics) using pre-mRNA gene models
each library, 16,000 cells were loaded onto a 10× chromium control- and default parameters to produce the cell by gene UMI count matrix.
ler to target a recovery of 10,000 cells. Libraries using the Chromium UMI counts were then analysed in R using the Seurat v.4 (ref. 60). We
Single Cell 3′ Reagent Kits (v.3.1) were prepared following the 10× user first filtered features detected in a minimum of three cells. Next, we
guide. Libraries were sequenced on a Novaseq S2 or S4 flow cell with a filtered high-quality cells based on the number of genes detected
target of 25,000 paired-end reads per cell. (minimum 1,000, maximum 8,000), removing cells with high mito-
 chondrial (less than 15%) or ribosomal (less than 20%) messenger RNA
Custom genomic reference. Each cell expresses eCas9 from a genomic content. Thereafter, expression matrices of high-quality cells were
locus (AAVS1) and a polyadenylated dual sgRNA cassette, which is de- normalized (LogNormalize) and scaled to a total expression of 10,000
livered by lentivirus and integrated into the genome. To cover these UMIs for each cell. Principal component analysis (PCA) was performed
extrinsic elements, we built a custom genomic reference for mapping based on the z-scaled expression of the 2,000 most variable features
10× single-cell data by amending the GRCh38 human reference. As (FindVariableFeatures()).
the individual gRNA sequences differed, we masked them by Ns so
as not to interfere with mapping (individual gRNA information is distin- Integration and annotation of single-cell transcriptomics data
guished in a separate counting pipeline). The sequences added covered To annotate the dataset, we first extracted cells with control gRNAs and
the genomic loci of AAVS1 with eCas9-dTomato-WPRE-SV40 and the merged them with cells from uninduced organoids (35,203 cells). We
masked lentiviral construct. integrated these unperturbed cells across libraries using Harmony61
 with default parameters. Using the integrated space, we clustered the
Emulsion PCR and target amplification dataset at a resolution of one using the Louvain algorithm62 and anno-
Emulsion polymerase chain reaction (PCR) was used to recover gRNA tated the clusters as dorsal and ventral telencephalons based on marker
and UCB sequences from plasmid libraries, genomic DNA extracted gene expression. We then split both trajectories and clustered again
from lentivirus-infected hES cells and cells sorted from CHOOSE mosaic with a resolution of two to annotate the cell types more finely. This
organoids as well as 10× single-cell complementary DNA libraries to annotation of unperturbed cells was used to perform a label transfer
reduce PCR bias and to prevent the generation of chimeric PCR prod- onto the full dataset with perturbed cells using Seurat. The full CHOOSE
ucts56,57. AmpliTaq Gold 360 master mix (ThermoFisher, catalogue no. dataset was further filtered for cells for which gRNAs were detected
4398876) was used for all PCR reactions. Emulsion PCR was performed and integrated across libraries using the Seurat anchoring method.
using the Micellula DNA Emulsion & Purification Kit (EURX, catalogue The integrated count matrix was log-normalized and scaled before
no. E3600) according to the manufacturer’s guide. For target amplifi- computing a PCA. To visualize the dataset, the first 20 principal comcation from 10× single-cell libraries, heminested emulsion PCRs were ponents were used to compute a UMAP embedding.
performed using the following primers:
 First PCR: forward primer (FW): 5′-gcagacaaatggctgaacgctgacg-3′, Assessment target gene expression in organoid and primary cell
reverse primer (RV): 5′-ccctacacgacgctcttccgatct-3′; second PCR: types
FW: 5′-ggagttcagacgtgtgctcttccgatcttgggaatcttataagttctgtatgagacc To assess how the target genes in our screen were expressed in organoid
actctttcc-3′, RV: 5′-ccctacacgacgctcttccgatct-3′. and primary tissue, we obtained gene expression data from cell clusters
 Amplicons were then indexed with unique NEB dual indexing primers, in the developing human brain32 from https://storage.googleapis.com/
and amplifications were monitored in a qPCR machine and stopped linnarsson-lab-human/HumanFetalBrainPool.h5. For both the primary
when reaching the logarithmic phase. Amplicons were sequenced using data and our organoid dataset, we summarized log-normalized expresthe Illumina Nextseq2000 or Novaseq6000 system. All primers used sion for each cell type (‘CellClass’ in the primary dataset) by computing
can also be found in Supplementary Table 1. the arithmetic mean. We visualized the expression of CHOOSE target
 genes with a heat map as displayed in Extended Data Fig. 6l,m.
gRNA and UCB recovery and analyses
gRNA sequences were extracted by cutting 5′- and 3′-flanking regions RNA velocity
with cutadapt (10% error rate, 1–3 nucleotide (nt) overlap, no indels)58. To obtain count matrices for spliced and unspliced transcripts, we
Sequences were filtered to be between 15 and 21 nt long. The corrected used kallisto (v.0.46.2)63 through the command line tool loompy from
cell barcode (CBC) and the unique molecular identifier (UMI) of each fastq from the python package loompy (v.3.0.7; https://linnarssonread were derived via the 10× Genomics Cell Ranger 6.0.1 alignment59. lab.org/loompy/). Using scVelo (v.0.2.4)31, moments were computed
Only reads with a corresponding gene expression (GEX) cell were based on the first 20 principal components using the function scvelo.
accepted. Reads and target sequences were joined by allowing partial pp.moments() with n_neighbors = 30. RNA velocity was subsequently
overlaps and hamming distances of two. Reads are counted towards calculated using the function scvelo.tl.velocity() (mode = ‘stochastic’),
unique CBC–UMI–gRNA combinations. A read count cutoff of 1% of the and a velocity graph was constructed using scvelo.tl.velocity_graph().
median read count of the UMI with the highest reads count per cell was To obtain a pseudotemporal ordering describing the two differentiaapplied. Cells with only one gRNA and more than one read were kept. tion trajectories, we first removed clusters annotated as cycling cells
In addition, within unique CBC–UMI combinations, only gRNA with (MKI67+) and astrocytes (S100B+) from the dataset. We then calcumore than 20% of the maximal read count of that group was kept. After lated a pseudotime based on the velocity graph using the function scv.
read filtering, UMIs were counted for each CBC–gRNA combination. tl.velocity_pseudotime() for both trajectories separately.
If more than one gRNA was found within a cell, only the gRNAs with
equal UMI count compared with the maximum UMI count were kept. Differential gRNA representation analysis
Only one-to-one combinations were considered further. Analogous To test whether perturbations affected fitness or proliferation capacity
to gRNA extraction, UCB was extracted with at least 6 nt overlap to of cells, we compared gRNA representation in eCas9-induced (n = 14
the flanks. Sequences with 12 nt length were selected and had to fol- pools of organoids from three batches) versus uninduced (n = 8 pools
low the synthesis pattern. Further processing was done analogous of organoids from two batches) samples. For each pool of organoids,
to gRNA. we computed the fractions of cells with each gRNA. We then computed

the average fold change of detection percentage between induced and gene set, we used all genes expressed in more than 5% of cells in our datauninduced samples and performed a two-sided t-test comparing both set. To perform gene ontology analysis, we used the function ‘enrichGO’
distributions. Multiple-testing correction on the resulting P values was from the R package clusterProfiler66 with ‘pAdjustMethod = ′fdr′’. We
performed using the Benjamini–Hochberg method. filtered the results using a significance threshold of FDR < 0.01. To test
 whether the set of TOP-DEGs was enriched for ASD-associated genes,
Differential abundance testing we first obtained a list of risk genes from SFARI (https://gene.sfari.org/
To assess how the perturbation of ASD risk genes changes abundances database/gene-scoring/, 11 April 2021). We then tested the enrichment
of different organoid cell populations, we tested for enrichment of using a Fisher exact test with all genes expressed in more than 5% of
each gRNA in each annotated cell state versus the control. To control cells in our dataset as the background. To assess the specificity of this
for confounding effects through differential gRNA sampling in differ- enrichment, we obtained a list of ID risk genes from sysID (936 primary
ent libraries, we used a CMH test stratified by library. Multiple-testing ID genes, https://sysndd.dbmr.unibe.ch, 17 March 2022) and tested for
correction was performed using the Benjamini–Hochberg method, enrichment among TOP-DEGs in the same way.
and a significance threshold of 0.05 was applied to the resulting FDR.
Enrichment effects were plotted using the signed −log10 FDR: that Processing of single-cell multiome data and GRN inference
is, the sign of the log odds ratio (effect size) multiplied by the −log10 Initial transcript count and peak accessibility matrices for the multiome
FDR-corrected P value. To further assess the variability of the differ- data were obtained from sequencing reads with Cell Ranger Arc and
ential abundance effects across independent pools of organoids, we further processed using the Seurat (v.4.0.1) and Signac (v.1.4.0)67 R packcomputed cell-type fold enrichment for each organoids pool and gRNA. ages. Peaks were called from the fragment file using MACS2 (v.2.2.6)68
For this, we used 14 scRNA-seq libraries obtained from independent and combined in a common peak set before merging. Transcript counts
pools of organoids as replicates from three batches. Two batches (11 were log-normalized, and peak counts were normalized using term
replicates) used non-targeting gRNA as a control, and a third batch frequency–inverse document frequency normalization. To assess the
(three replicates) used eCas9-uninduced cells as an alternative control. cell composition of the multiome data, integration with the CHOOSE
We additionally computed a background distribution of enrichment scRNA-seq data was performed using Seurat (FindIntegrationAnchors()
effects from randomly permuted gRNA labels. We then performed -> IntegrateData()) with default parameters. As a preprocessing step
a t-test for each perturbation and cell type against this background to GRN inference with Pando41, chromatin accessibility data were first
distribution. coarse grained to a high-resolution cluster level. For this, control cells
 from the CHOOSE dataset were combined with the multiome dataset,
Local cell compositional enrichment test and Louvain clustering was performed at a resolution of 20 based on the
To visualize the compositional changes induced by the genetic pertur- first 20 principal components calculated from the 2,000 most variable
bations at a finer resolution, we used a method outlined in Nikolova features (RNA). For each cluster, peak accessibility was summarized
et al.64 In brief, a k-nearest neighbour (kNN) graph (k = 200) of cells was by computing the arithmetic mean from binarized peak counts so
constructed on the basis of Euclidean distance on the PCA-reduced CCA that each cell in the cluster was represented by the detection prob-
(canonical-correlation analysis) space. Next, a CMH test stratified by ability vector of each peak. To constrain the set of peaks considered by
library was performed on the neighbourhood of each cell, comparing Pando, we used the union of PhastCons conserved elements69 from an
frequencies of the gRNA or gRNA pool and the pool of control gRNAs alignment of 30 mammals (obtained from https://genome.ucsc.edu/)
within and outside of the neighbourhood. The resulting neighbourhood and candidate cis-regulatory elements derived from the ENCODE proenrichment score of each cell was defined as signed −log(P), where the ject70 (initiate_grn()). In these regions, we scanned for TF motifs (find_
sign was determined by the sign of the log-transformed odds ratio. motifs()) based on the motif database shipped with Pando, which was
A random walk with restart procedure was then applied to smooth compiled from motifs derived from JASPAR and CIS-BP. Based on motif
the neighbourhood enrichment score of each cell. The smoothened matches, cell-level log-normalized transcript counts and cluster-level
enrichment scores were visualized on the UMAP embedding using the peak accessibilities, we then inferred the GRN using the Pando function
ggplot2 (ref. 65) function stat_summary_hex() (bins = 50). infer_grn() (peak_to_gene_method = ‘GREAT’, upstream = 100,000,
 downstream = 100,000) for the 5,000 most variable features. Here,
Differential expression analysis genes were associated with candidate regulatory regions in a 100,000
To investigate the transcriptomic changes caused by each perturba- radius around the gene body using the method proposed by GREAT71.
tion, we performed differential expression analysis based on logistic From the model coefficients returned by Pando, TF modules were
regression. We used the Seurat function FindMarkers() (test.use = ‘LR’) constructed using the function find_modules() (P_thresh = 0.05, rsq_
to find DEGs for each gRNA label versus control. Tests were performed thresh = 0.1, nvar_thresh = 10, min_genes_per_module = 5). To visualon log-normalized transcript counts Y while treating library, cell_type ize subnetworks centred around one TF, we computed the shortest
and n_UMI as covariates in the model: path from the TF to every gene in the GRN graph. If there were multiple
 shortest paths, we retained the one with the lowest average P value.
 Yi ≈ n_UMI + library + cell_type + condition. The resulting graph was visualized with the R package ggraph (https://
 github.com/thomasp85/ggraph) using the circular tree layout.
 Testing within each developmental trajectory was performed by
omitting the cell_type covariate. Multiple-testing correction was per- Enrichment testing for TF modules
formed using the Benjamini–Hochberg method, and a significance To find subnetworks of the GRN at which ASD-associated genes accuthreshold of 0.05 was applied to the resulting FDR to obtain a set of mulate, we first obtained a list of ASD risk genes from SFARI (https://
DEGs (CHOOSE DEGs). We further selected top 30 DEGs on the basis gene.sfari.org/database/gene-scoring/). For all genes included in SFARI
of absolute fold change for each gRNA (TOP-DEGs). (1,031 genes), we tested for enrichment in TF modules using a Fisher
 exact test. All genes expressed in more than 5% of cells in our dataset
DEG enrichment analysis (12,079 genes) were treated as the background. Fisher test P values
To assess the biological processes in which the detected DEGs were were corrected for multiple testing using the Benjamini–Hochberg
involved, we performed gene ontology enrichment across all TOP-DEGs method, and significant enrichment was defined as FDR < 0.01 and
globally as well as using all detected DEGs for each target gene in excita- more than twofold enrichment (odds ratio). To assess which TF modtory and inhibitory neuron trajectories separately. As a background ules were most affected by genetic perturbations of ASD-associated

Article
genes, we similarly used a Fisher exact test. For the set of TOP-DEGs, from each organoid were selected using the Hoechst channel. In total,
we tested for enrichment in any of the inferred TF modules. Here, all n = 108 areas (13 organoids from four batches) from the ARID1B congenes included in the GRN (5,000 most variable features) were treated trol group (c.2201dupG repair), n = 104 areas (15 organoids from four
as the background. batches) from the ARID1B+/− (c.2201dupG) group and n = 94 areas (15
 organoids from three batches) from the ARID1B+/− (6q25.3del) group
Cell rank analysis are collected and subjected to an automatic segmentation using a Fiji
To better understand the differentiation trajectories leading up to macro. Both DLX2 and OLIG2 channels are used to define the cell body
inhibitory neuron populations, we used CellRank43 to compute transi- area, followed by the intensity measurement. Area mean intensity was
tion probabilities into each terminal fate based on the previously com- used for setting up the threshold. For protein expression quantification
puted velocity pseudotime. First, the clusters with the highest in Extended Data Fig. 2, organoids with individual gene perturbations
pseudotime for each terminal cell state were annotated as terminal costained for each gene were processed and quantified using Fiji. Five
states. We then constructed a Palantir kernel72 (PalantirKernel()) based to fourteen cortical plate regions were analysed per gene. Areas conon velocity pseudotime and used Generalized Perron Cluster Cluster taining both uninduced (dTomato−) as well as induced (dTomato+)
Analysis73 (GPCCA()) to compute a terminal fate probability matrix cells were selected and subjected to an automated segmentation
(compute_absorption_probabilities()). All cell rank functions were run using a Fiji macro. The Hoechst channel is used to define the cell body
with default parameters. Fate probabilities for each cell were visualized area, followed by intensity measurement. Detected cells were sepausing a circular projection74. In brief, we evenly spaced terminal states rated into wild-type and perturbed cells by setting up a threshold of
around a circle and assigned each state an angle t. We then computed mean intensity in the dTomato channel. Additionally, KMT2C protein
two-dimensional coordinates ( xi, yi) from the F ∈ R Nxn t transition prob- expression was compared between wild-type (dTomato−) and mutant
ability matrix for N cells and nt terminal states as (dTomato+) VZ area. VZs were individually outlined, and mean dTo-
 mato as well as KMT2C intensities were measured. For IPC abundance
 xi = ∑ fit cosαt analysis, organoids with individual gene perturbations were costained
 t
 for EOMES. Mutant columns expressing dTomato were individually
 segmented, and EOMES+ cells were identified by setting a threshold
 yi = ∑ fit sinαt . for EOMES intensity. The number of EOMES+ cells was normalized to
 t
 the total number of cells. Percentages of EOMES+ cells were compared
 between individual gene perturbations and non-targeting gRNA control
 To visualize enrichment of perturbed cells in this space, we used groups. For INP abundance analysis, organoids were costained with
the method outlined in Nikolova et al.64. Here, the kNN graph (k = 100) DLX2. A Fiji macro for automated segmentation was used to identify
was computed using euclidean distances in fate probability space, and DLX2+ cells throughout the entire tissue. Areas containing multiple
enrichment scores were visualized on the circular projection. Other- rosettes from each organoid were collected for quantification. The
wise, the method was performed as described above. number of DLX2+ cells was normalized to the tissue area and com-
 pared between individual gene perturbations and non-targeting gRNA
Immunofluorescence control groups.
Organoid tissues were fixed in paraformaldehyde at 4 °C overnight
followed by washing in PBS three times for 10 min. Tissues were then Patient sample collection
allowed to sink in 30% sucrose overnight, followed by embedding in The study was approved by the local ethics committee of the Medical
O.C.T. compound (Sakura, catalogue no. 4583). Tissues were frozen on University of Vienna. Study inclusion criteria were as follows: (1) mutadry ice and cryosectioned at 20 μm. For staining, sections were first tion in the ARID1B gene proven by whole-exome sequencing, (2) age
blocked and permeabilized in 0.1% Triton X-100 in PBS (0.1% PBTx) between 0 and 18 years old, (3) continuous follow-up at the Vienna Genwith 4% normal donkey serum. Sections were then stained with pri- eral Hospital and (4) availability of fetal brain MRI data. After informed
mary and secondary antibodies diluted in 0.1% PBTx with 4% normal consent, 10 ml of blood was collected from two selected patients for
donkey serum. Sections were washed in PBS three times for 10 min after iPS cell reprogramming.
each antibody staining and mounted in DAKO fluorescent mounting
medium (Agilent Technologies, catalogue no. S3023). The following Reprogramming of PBMCs into iPS cells
antibodies were used in this study: DLX2 (Santa Cruz, catalogue no. iPS cells were generated from peripheral blood mononuclear cells
SC393879, 1:100); OLIG2 (Abcam, catalogue no. ab109186, 1:100); SOX2 (PBMCs) isolated from patient blood samples as previously described75.
(R&D, catalogue no. MAB2018, 1:500); FOXG1 (Abcam, catalogue no. In brief, 10 ml blood was collected in sodium citrate collection tubes.
ab18259, 1:200); EOMES (R&D, catalogue no. AF6166, 1: 200); ARID1B PBMCs were isolated via a Ficoll–Paque density gradient, and erythro-
(Cell Signaling, catalogue no. 92964, 1:100); ADNP (ThermoFisher, blasts were expanded for 9 days. Erythroblast-enriched populations
catalogue no. 702911, 1:250); BCL11A (Abcam, catalogue no. 191401, were infected with Sendai Vectors expressing human OCT3/4, SOX2,
1:250); PHF3 (Sigma, catalogue no. HPA024678, 1:250); SMARCC2 (Ther- KLF4 and cMYC (CytoTune; Life Technologies, A1377801). Three days
moFisher, catalogue no. PA5-54351, 1:250); KMT2C (Sigma, catalogue after infection, cells were switched to mouse embryonic fibroblast
no. HPA074736, 1:250); Alexa 488, 568 and 647 conjugated secondary feeder layers. Five days after infection, the medium was changed to
anti-bodies (ThermoFisher, 1:250); and Hoechst (ThermoFisher, cata- iPS cell medium (KoSR + FGF2). Ten to 21 days after infection, the translogue no. H3569, 1:10,000). duced cells began to form colonies that exhibited iPS cell morphology.
 iPS cell colonies were picked and passaged every 5–7 days after transfer
Microscopy, image processing and quantification to the mTeSR culture system (Stemcell Technologies).
Tissue sections were imaged using an Olympus IX3 Series inverted
microscope equipped with a dual-camera Yokogawa W1 spinning disk. Generation of isogenic control cell line for patient 1
Images were acquired with 10× 0.75 (air) working distance (WD) 0.6 mm Isogenic control cell lines for patient 1 were generated using CRISPR–
or 40× 0.75 (air) WD 0.5 mm objectives and produced by the Cellsense Cas9. Streptococcus pyogenes Cas9 protein with two nuclear localization
software. signals was purified as previously described76. gRNA transcription was
 For DLX2 and OLIG2 quantification in Fig. 4, images were processed performed with the HiScribe T7 High Yield RNA Synthesis Kit (NEB)
and quantified using Fiji. Based on the size of the tissue, 5–12 regions according to the manufacturer’s protocol, and gRNAs were purified

via phenol:chloroform:isoamyl alcohol (25:24:1; Applichem) extraction data were generated and calculations for the GE were made based on
followed by ethanol precipitation. The homology-directed repair (HDR) the investigated gestational ages.
template (custom single-stranded oligodeoxynucleotides; Integrated
DNA Technologies) was designed to span 100 base pairs up- and down- Statistics
stream of the mutation site. iPS cells had been grown in mTeSR for 14 Information on the statistical analyses used is described in each method
passages before the procedure. For generation of isogenic control cell section. No statistical methods were used to predetermine sample
lines, cells were washed with DPBS−/− and incubated for 5 min at 37 °C size unless specified. No blinding and randomization were used unless
with 1 ml of accutase solution (Sigma-Aldrich, A6964-500ML). The plate specified.
was gently tapped to detach cells, and cells were gently pipetted to
generate a single-cell suspension, pelleted by spinning at 200g for 3 min Reporting summary
and counted using Trypan Blue solution (ThermoFisher Scientific). Further information on research design is available in the Nature Port-
For nucleofection, 1.0 × 106 cells were spun down and resuspended in folio Reporting Summary linked to this a­rt­ic­le.
Buffer R of the Neon Transfection System (ThermoFisher Scientific)
at a concentration of 2 × 107 cells per millilitre. Twelve nanograms of
sgRNA and 5 ng of Cas9 protein were combined in resuspension buffer Data availability
to form the Cas9–sgRNA ribonucleoprotein complex. The reaction Raw sequencing datasets were deposited into ArrayExpress with the
was mixed and incubated at 37 °C for 5 min. Five microliters of the HDR following accession codes: single-cell RNA sequencing and associtemplate (100 μM) were added to the Cas9–sgRNA ribonucleoprotein ated amplicon (E-MTAB-13148), bulk genomic DNA-derived amplicon
complex and combined with the cell suspension. Electroporations (E-MTAB-13140) and single-cell mutiomics (E-MTAB-13144). ARID1B cell
were performed using a Neon Transfection System (ThermoFisher line genotype data were deposited into the European Genome-Phenome
Scientific) with 100 μl Neon Pipette Tips using the embryonic stem Archive (EGAS00001007381). Processed Seurat objects were deposited
cells electroporation protocol (1,400 V, 10 ms, three pulses). Cells were into Zenodo (https://zenodo.org/record/7083558).
seeded in one matrigel-coated well of a six-well plate in mTeSR. After
a recovery period of 3 days, a single-cell suspension was generated,
and cells were split into another well of a six-well plate for banking Code availability
and sparsely into two 10-cm dishes for colony formation from single The Pando R package is available on GitHub (https://github.com/
cells. After colony growth for 1 week, individual colonies were picked quadbiolab/Pando). Other custom code used in the analyses has been
and seeded each into one well of a 96-well plate. After colony expan- deposited on GitHub (https://github.com/quadbiolab/ASD_CHOOSE).
sion, gDNA was extracted using DNA QuickExtract Solution (Lucigen),
followed by PCR and Sanger sequencing to determine efficient repair 54. Michlits, G. et al. Multilayered VBC score predicts sgRNAs that efficiently generate loss-of-
 function alleles. Nat. Methods 17, 708–716 (2020).
of the mutation.
 55. Sanjana, N. E., Shalem, O. & Zhang, F. Improved vectors and genome-wide libraries for
 CRISPR screening. Nat. Methods 11, 783–784 (2014).
Fetal MRI and 3D reconstruction 56. Omelina, E. S., Ivankin, A. V., Letiagina, A. E. & Pindyurin, A. V. Optimized PCR conditions
 minimizing the formation of chimeric DNA molecules from MPRA plasmid libraries. BMC
Women with singleton pregnancies undergoing fetal MRI at a tertiary
 Genom. 20, 536 (2019).
care centre from January 2016 to December 2021 were retrospec- 57. Williams, R. et al. Amplification of complex gene libraries by emulsion PCR. Nat. Methods
tively reviewed. This study was approved by the institutional ethics 3, 545–550 (2006).
 58. Martin, M. Cutadapt removes adapter sequences from high-throughput sequencing reads.
board, and all examinations were clinically indicated. A retrospective
 EMBnet J 17, 10–12 (2011).
review of patient records was performed, and a patient with a positive 59. Zheng, G. X. Y. et al. Massively parallel digital transcriptional profiling of single cells. Nat.
genetic testing report for ARID1B mutation was selected. The partici- Commun. 8, 14049 (2017).
 60. Hao, Y. et al. Integrated analysis of multimodal single-cell data. Cell 184, 3573–3587.e29
pant was included in further analysis, and the gestational age (given (2021).
in gestational weeks and days postmenstruation) was determined by 61. Korsunsky, I. et al. Fast, sensitive and accurate integration of single-cell data with Harmony.
first-trimester ultrasound. High-quality super-resolution reconstruc- Nat. Methods 16, 1289–1296 (2019).
 62. Blondel, V. D., Guillaume, J.-L., Lambiotte, R. & Lefebvre, E. Fast unfolding of communities
tion was obtained13. Age-matched control subjects were identified in large networks. J Statist. Mech. Theory Exp. 2008, P10008 (2008).
and included if they presented an absence of confounding comorbidi- 63. Bray, N. L., Pimentel, H., Melsted, P. & Pachter, L. Near-optimal probabilistic RNA-seq
ties, including structural cerebral or cardiac anomalies or fetal growth quantification. Nat. Biotechnol. 34, 525–527 (2016).
 64. Nikolova, M. T. et al. Fate and state transitions during human blood vessel organoid
restriction. development. Preprint at bioRxiv https://doi.org/10.1101/2022.03.23.485329 (2022).
 Fetal MRI scans were conducted using 1.5-T (Philips Ingenia/Intera) 65. Wickham, H. in ggplot2: Elegant Graphics for Data Analysis 147–168 (Springer, 2016).
and 3-T magnets (Philips Achieva). The mother was examined in a supine 66. Wu, T. et al. clusterProfiler 4.0: a universal enrichment tool for interpreting omics data.
 Innovation 2, 100141 (2021).
position or if necessary, left recumbent to achieve sufficient imag- 67. Stuart, T., Srivastava, A., Madad, S., Lareau, C. A. & Satija, R. Single-cell chromatin state
ing quality. The examinations were performed within 45 min, neither analysis with Signac. Nat. Methods 18, 1333–1341 (2021).
sedation nor MRI contrast medium was applied, and both the fetal 68. Feng, J., Liu, T., Qin, B., Zhang, Y. & Liu, X. S. Identifying ChIP-seq enrichment using MACS.
 Nat. Protoc. 7, 1728–1740 (2012).
head and body were imaged. Fetal brain imaging included T2-weighted 69. Siepel, A. et al. Evolutionarily conserved elements in vertebrate, insect, worm, and yeast
sequences in three orthogonal planes (slice thickness = 3–4 mm, echo genomes. Genome Res. 15, 1034–1050 (2005).
time = 140 ms, field of view = 230 mm) of the fetal head. Postprocess- 70. Consortium, T. E. P. et al. Expanded encyclopaedias of DNA elements in the human and
 mouse genomes. Nature 583, 699–710 (2020).
ing was conducted as previously described77. Superresolution imag- 71. McLean, C. Y. et al. GREAT improves functional interpretation of cis-regulatory regions.
ing was generated using a volumetric superresolution algorithm77. Nat. Biotechnol. 28, 495–501 (2010).
The resulting superresolution data were quality assessed, and only 72. Setty, M. et al. Characterization of cell fate probabilities in single-cell data with Palantir.
 Nat. Biotechnol. 37, 451–460 (2019).
cases that met high-quality standards (score of less than or equal to 73. Reuter, B., Weber, M., Fackeldey, K., Röblitz, S. & Garcia, M. E. Generalized Markov state
two of five) were included in the analysis. Atlas-based segmentation modeling method for nonequilibrium biomolecular dynamics: exemplified on amyloid β
was performed for the fetal cortex and total brain volume by nonrigid conformational dynamics driven by an oscillating electric field. J. Chem. Theory Comput.
 14, 3579–3594 (2018).
mapping of a publicly available spatiotemporal, anatomical fetal brain 74. Velten, L. et al. Human haematopoietic stem cell lineage commitment is a continuous
atlas for each investigated case77,78. Segmentation of the GE was per- process. Nat. Cell Biol. 19, 271–281 (2017).
formed manually using the open-source application ITK-SNAP79. To 75. Agu, C. A. et al. Successful generation of human induced pluripotent stem cell lines from
 blood samples held at room temperature for up to 48 hr. Stem Cell Rep. 5, 660–671 (2015).
delineate the T2-weighted hypointense GE, histological fetal atlases 76. Jinek, M. et al. A programmable dual-RNA–guided DNA endonuclease in adaptive bacterial
by Bayer and Altman80,81 were used as a reference guide. Volumetric immunity. Science 337, 816–821 (2012).

Article
77. Gholipour, A. et al. A normative spatiotemporal MRI atlas of the fetal brain for automatic the Chan Zuckerberg Initiative DAF, an advised fund of the Silicon Valley Community Foundation
 segmentation and analysis of early brain growth. Sci. Rep. 7, 476 (2017). (grant no. CZF2019-002440); the Swiss National Science Foundation (grant no. 310030_192604);
78. Yushkevich, P. A. et al. User-guided 3D active contour segmentation of anatomical and the National Centre of Competence in Research Molecular Systems Engineering. A.V.
 structures: significantly improved efficiency and reliability. Neuroimage 31, 1116–1128 is supported by an EMBO Fellowship (grant no. ALTF-1112-2019). J.S.F. was supported by a
 (2006). Boehringer Ingelheim Fonds PhD fellowship. C.M.-C. was supported by the SCORPION Austrian
79. Ebner, M. et al. An automated framework for localization, segmentation and super- Science Fund (FWF) DOC 72-B27.
 resolution reconstruction of fetal brain MRI. Neuroimage 206, 116324 (2020).
80. Bayer, S. A. & Altman, J. The Human Brain During the Second Trimester (1st ed.) https://doi. Author contributions C.L. and J.A.K. conceived the project and experimental design and
 org/10.1201/9780203507483 (CRC, 2005). secured the funding. C.L., J.S.F. and J.A.K. prepared the manuscript with input from all authors.
81. Bayer, S. A. & Altman, J. The Human Brain During the Third Trimester (1st ed.) https://doi. C.L. performed all the experiments and analysed the data with the help of T.R.B., J.T., A.M.P.,
 org/10.1201/9780203494943 (CRC, 2003). A.V., J.B.L. and C.E. J.S.F. performed the analysis of all single-cell RNA sequencing and
 multiome data under the supervision of B.T. M.S. and G.K. performed patient diagnosis and
 analysed magnetic resonance imaging. C.M.-C. generated induced pluripotent stem cell
Acknowledgements We thank the patients and their families for participating in this study. lines under the supervision of N.S.C. U.E. provided sgRNA predication.
We thank all members of the laboratory of J.A.K. for support and discussions; F. Bonnay,
E. Chatzidaki, O. L. Eichmüller, R. Najm and J. Sidhaye for comments on the manuscript; Competing interests J.A.K. is on the supervisory and scientific advisory board of a:head bio
M. Nezhyba and T. Lendl from the IMP/IMBA Biooptics Facility for technical support; A. Vogt, AG (https://aheadbio.com) and is an inventor on several patents relating to cerebral organoids.
F. Drochter and T. Grentzinger from the VBCF NGS facility for single-cell RNA sequencing The remaining authors declare no competing interests.
library preparation; the IMBA Stem Cell Core facility for generation of induced pluripotent
stem cell lines; and M. Balmana Esteban and the Christoph Bock group (CeMM) for the help Additional information
with single-cell multiomics sequencing. Work in the laboratory of J.A.K. is supported by SFARI Supplementary information The online version contains supplementary material available at
(pilot award no. 724430); the Austrian Federal Ministry of Education, Science and Research; https://doi.org/10.1038/s41586-023-06473-y.
the Austrian Academy of Sciences; the City of Vienna; the Austrian Science Fund (FWF) Special Correspondence and requests for materials should be addressed to Chong Li,
Research Programme (grant no. F 7804-B) and two Stand-Alone grants (grant no. P 35680 and Barbara Treutlein or Juergen A. Knoblich.
no. P 35369); and a European Research Council (ERC) Advanced Grant under the European Peer review information Nature thanks the anonymous reviewer(s) for their contribution to the
Union’s Horizon 2020 programs (grant no. 695642 and no. 874769). Work in the laboratory of peer review of this work. Peer reviewer reports are available.
B.T. is supported by the European Research Council (organomics and braintime (to B.T.)); Reprints and permissions information is available at http://www.nature.com/reprints.

Extended Data Fig. 1 | A gRNA reporter assay to determine gRNA efficiency. internal control cells (GFP-) are subjected to FACS-based analysis at 20 dpi.
a, Diagram of the lentiviral construct delivering dual-sgRNA cassette and Efficient editing causing frameshift mutations lead to the loss of BFP
eCas9 under the spleen focus forming virus (SFFV) promotor. Lentivirus fluorescence. c, Four dual-sgRNA examples show no (0–10% reduction), mild
infected cells are labelled with GFP. Retroviral transduction is used to generate (10–45% reduction), medium (45–75% reduction) and strong editing efficiency
3T3 cell lines. A pre-assembled array of gRNA-targeting sequences is fused with (> 75% reduction) at 20 dpi, respectively, based on median fluorescence
TagBFP. b, Flow cytometry graph shows a 3T3 reporter cell line is positive for intensity. d, 98 pairs of gRNAs were tested and categorized into four groups.
both BFP and Tomato. After lentiviral infection, transduced cells (GFP+) and e, Editing efficiency of selected paired gRNAs from 36 ASD genes.

Article


Extended Data Fig. 2 | Perturbations of ASD genes efficiently decrease points and median values; each data point represents a single cell; cells were
protein expression levels. a, Confocal images showing IHC analyzes of protein measured from 4 organoids) showing quantification of protein expression
expression levels in organoids with individual genes perturbed (ADNP, ARID1B, levels, as measured by fluorescent intensity. Bar plot (mean ± S.D., n = 3 areas
PHF3, SMARCC2, KMT2C). Note that both wild-type (dTomato-) and perturbed from 3 individual organoid) showing quantification of protein expression
cells (dTomato+) present in each organoid. Arrowheads and dotted lines indicate levels from eCas9-uninduced and induced VZ area. Two-sided student’s t-test.
perturbed cells or ventricular zones, respectively. b, Violin plots (all data *P < 0.05, **P < 0.01. Scale bar, 100 μm.

Extended Data Fig. 3 | gRNA library, infection and integration of CHOOSE cassette after the lentiviral integration into the host genome. FW and RV are
lentivirus in hES cells. a, Plot showing cumulative fraction of uniquely paired primers used to demonstrate the successful integration of the lentivirus.
barcoded gRNA cassettes from the CHOOSE ASD plasmid library. b, Plot The primers amplify specific regions of the genomic DNA extracted from
showing cumulative fraction of uniquely barcoded gRNA cassettes separated lentivirus-infected hES cells, and the lentiviral plasmid. e, Representative gel
by each target gene from the plasmid library. c, Infection rate of CHOOSE electrophoresis analysis from 2 independent experiments showing 12 kb and
lentivirus on hES cells determined by flow-cytometry. Infected cells are 13 kb bands detected from gDNA and plasmid respectively.
positive for GFP. d, Top diagram showing the duplication of the dual-sgRNA

Article


Extended Data Fig. 4 | See next page for caption.

Extended Data Fig. 4 | Clonal diversity of the CHOOSE organoids. a,b, Reads Each data point represents one clone. f, Violin plot showing the average size
distribution for each barcoded gRNA cassette from the plasmid library (a) and of total clones recovered for each perturbation. g, h, Box plots (minimum,
from genomic DNA (b) extracted from the hES cells infected by lentivirus. c, Box maximum and median values; all data points) showing the number of clones
plot (minimum, maximum and median values; all data points) showing clone recovered from bulk genomic DNA extracted from eCas9-induced and
numbers recovered from scRNAseq libraries. Each data point represents a uninduced cells. Each data point represents a bulk genomic DNA sample
scRNAseq library. n = 11 independent pools (libraries) of organoids as replicates, (50,000–150,000 cells sorted from pooled organoids). n = 5 pools of organoids
2 batches. d, Bar plot showing total clone numbers for each perturbation for eCas9-induced cells; n = 11 pools of organoids for eCas9-uninduced cells.
recovered from 11 scRNAseq libraries. e, Violin plot showing clone size UCB, unique clone barcode.
distribution for each perturbation recovered from 11 scRNAseq libraries.

Article


Extended Data Fig. 5 | See next page for caption.

Extended Data Fig. 5 | Generation of cerebral organoids using the CHOOSE SOX2 is a marker for progenitor cells. FOXG1 is a marker for tissues with
system. a, Schematic showing the protocol used for generating cerebral telencephalon identity. d, FACS plots showing percentages of eCas9-induced
organoids. 4-OHT was added to induce eCas9 expression at day 5. A short 3-day cell population (GFP+/dTomato+) at day 30. Organoids are treated with different
CHIR treatment was applied from day 12–14. Culture medium was switched to concentrations of 4-OHT at day 5. e, FACS plots showing percentages of eCas9-
Brainphys after day 60 for advanced neuronal maturation. Tissues are collected induced cell population at different developmental stages when organoids are
at day 120 and subjected to scRNA-seq assays. b, ES cells were infected by treated with 0.3 ug/ml 4-OHT. f, Bar plot (mean ± S.D.) showing average eCas9
lentivirus and GFP positive cells were collected to make EBs. Microscopic induction rate at day 120 when organoids are treated with 0.3 ug/ml 4-OHT.
images show the overall morphology and GFP expression of cerebral organoids Each dot indicates a pool of 3–7 organoids. n = 9 biologically independent pools
overtime. Top, bright-field; Bottom, GFP fluorescence. Scale bar, 100 μm. of organoids, examined over 2 independent experimental batches. Data are
c. Immunohistochemical staining of cerebral organoids on day 24. GFP labels presented as mean values ± SD.
cells infected with lentivirus and Tomato is a reporter for eCas9 expression.

Article


Extended Data Fig. 6 | Cell type and gRNA composition of scRNA-seq samples filtered for gRNA detection. Cells are coloured by perturbation
libraries. a, Histograms showing UMI count and number of detected features status (e,h) and batch (f,i). g,j, Feature plots showing expression of marker
in the QC-controlled scRNA-seq dataset for each batch of organoids. b, Bar plot genes on a UMAP embedding for unperturbed cells (g) and full CHOOSE
showing numbers of recovered cells with assigned gRNAs for each library. dataset ( j). k, UMAP embedding coloured by velocity pseudotime to show
c, Bar plots showing cell number and gRNA composition for each replicate split developmental directions. l,m, Heatmaps showing expression of perturbed
by batch. d, UMAP embedding of unperturbed cells (control gRNA and eCas9- target genes in cerebral organoid cell types (l) and cell types in the developing
uninduced) coloured by annotated cell type. e,f,h,i, UMAP embedding of the human brain (Braun et al. 32) (m).
unperturbed cells and full CHOOSE dataset including induced and uninduced

Extended Data Fig. 7 | gRNA representation in eCas9-induced and within each circle indicate batch numbers. Note batch 3 does not include
uninduced cell populations of the CHOOSE organoids. a, Bar plots showing non-targeting gRNA control and uses internal eCas9-uninduced cells as an
gRNA representation in scRNAseq libraries (pink circle; each library is an alternative control. b, Bar plot showing gRNA representation in bulk genomic
independent pool of organoids) and in bulk genomic DNA extracted from DNA extracted from eCas9-induced and uninduced cell populations sorted
eCas9-induced and uninduced cell populations (blue circle; each sample is from organoid pools at different development stages.
sorted from an independent pool of organoids) at 4 months. The numbers

Article


Extended Data Fig. 8 | Perturbations of ASD risk genes lead to cell number of induced cells divided by the number of un-induced cells sorted from
proliferation or depletion. a, Schematic showing organoids perturbed the same pool of organoids, and compared to non-targeting gRNA control.
with individual genes are subjected to phenotypic characterizations through One-way ANOVA post hoc Fisher’s LSD test. *P < 0.05, **P < 0.01. d, Confocal
FACS and IHC analyzes. Note that wild-type (eCas9-) and perturbed (eCas9+) images showing representative images of organoids with individual genes
cells present in each organoid. b, c, Bar plots (mean ± S.D., n = 3 (b) or 5 (c) perturbed. IHC analyzes were performed on 60-day-old organoids from at least
biologically independent pools, each pool contains 3 organoids) showing 4 organoids over two independent batches. GFP labels cells expressing gRNA
perturbation-induced over-proliferation (KMT2C and LEO1) and depletion construct and dTomato indicates the induction of eCas9. Scale bar, 200 μm.
(ADNP and WAC). Over-proliferation and depletion were calculated using the

Extended Data Fig. 9 | Cell type compositional changes caused by ASD gene control indicated by red (enrichment) or blue (depletion). b, UMAP embedding
perturbations. a, UMAP embeddings show single cell distribution for each of the scRNA-seq dataset containing dorsal and ventral telencephalon
perturbed gene. Local cell composition differences of perturbation versus trajectories.

Article


Extended Data Fig. 10 | Differential abundance effects of perturbations against a permuted background distribution to highlight highly consistent
across independent pools of organoids. Lolliplots showing effect size of effects across replicates. Stars indicate statistical significance in the single
differential abundance (log odds ratio) per cell type and target gene. Dot cell-level test, diamonds indicate significance of a two-sided t-test across pools
colour indicates batch, size indicates number of cells. A t-test was performed of organoids (P < 0.05).

Extended Data Fig. 11 | Perturbations of ASD risk genes lead to depletion of Note the presence of EOMES+ cells in the SVZ. e, Bar plot (mean ± S.E.M.; all data
IPs. a-d, Confocal images showing immunohistochemical staining of EOMES points; from left to right, n = 14, 14, 14, 12 areas collected from 4 organoids for
on 60-day-old organoids perturbed with individual genes. dTomato labels each perturbation) showing quantification of percent EOMES+ cells per eCas9
eCas9-induced cells. Yellow box labels radially organized structure with positive column area. Individual perturbations are compared to non-targeting
ventricular zone (VZ), subventricular zone (SVZ) and cortical plate (CP). gRNA control. Two-sided student’s t-test. *P < 0.05, **P < 0.01. Scale bar, 100 μm.

Article


Extended Data Fig. 12 | Perturbations of ASD risk genes lead to enrichment showing quantification of the number of DLX2+ cells per 100 μm2 area.
of INPs. a, Confocal images showing immunohistochemical staining of DLX2 Areas containing multiple rosettes from each organoid were collected for
on 60-day-old organoids perturbed with individual genes. dTomato labels quantification. Individual perturbations are compared to non-targeting gRNA
eCas9-induced cells. b, Bar plot (mean ± S.E.M.; all data points; from left to control. Two-sided student’s t-test. *P < 0.05, **P < 0.01. Scale bar, 500 μm.
right, n = 16, 18, 16, 30 areas collected from 4 organoids for each perturbation)

Extended Data Fig. 13 | Differential expression and GO enrichment analysis b, Bar plot showing perturbation-specific GO enrichment of DEGs in dorsal
of ASD genetic perturbations. a, Scatter plot showing differential expression and ventral telencephalon cells. As a background gene set we used all genes
log fold change in dorsal and ventral telencephalon cells for LEO1 and KMT2C. expressed in >5% of cells in the dataset.
Dot colour indicates the trajectory where the gene was differentially expressed.

Article


Extended Data Fig. 14 | See next page for caption.

Extended Data Fig. 14 | Quality control and GRN inference from the single- GAD2 (ventral marker) and NEUROD6 (dorsal marker). h, Density scatter plot
cell multiome dataset. a, Histograms showing UMI count and number of histograms showing the distributions of explained variance (x) and number of
detected features for RNA as well as fragment count and number of detected variables (y) in the fitted models for GRN construction. Dashed lines indicate
peaks for ATAC. b, Histogram showing distribution of transcription start site the thresholds used for model selection. i, Boxplots showing the distribution of
(TSS) enrichment scores across cells. c, Line plot showing TSS enrichment peaks (left) and TFs assigned per gene (middle, n = 864), and number of genes
score at each position relative to the TSS. d, Histogram showing distribution assigned per TF (right, n = 241) in the inferred GRN. The centre line represents
of fragment length. e, UMAP embedding showing multiome data (black) the median, the box limits show the 25–75% interquartile range and the whiskers
integrated with the CHOOSE dataset. Multiome data were used in conjunction indicate 1.5× the interquartile range. j, Lolliplot showing the enrichment of
with the control cells from the CHOOSE dataset (grey) to infer the GRN with ASD-associated genes from SFARI in inferred TF modules. Red colour indicates
Pando. f, Feature plots showing expression of marker genes on the UMAP an FDR-corrected two-sided Fisher-test p-value of <0.01. Dot size indicates the
embedding. g, Genomic tracks showing accessible peaks in the proximity of total number of genes in the module.

Article


Extended Data Fig. 15 | An ARID1B patient had enlarged ganglionic control. Sequencing was done on fragments amplified from genomic DNA
eminence. a, Graph representation of AR, PBX1, DLX6, OTX2, and OLIG1 TF extracted from the two iPS cell lines. c, SNP array genotyping of PBMCs and
modules, which are most strongly enriched in ARID1B DEG (Two-sided Fisher iPS cells from patient 2 shows a microdeletion (dark green arrow) identified on
exact test p-value < 0.01, top 4 odds ratio). The targets highlighted in yellow chromosome 6. d-f, Bar plot showing the absolute GE (d), cortex (e) and total
are SFARI genes, and the targets highlighted in black are TF modules enriched brain (f) volumes of control (mean ± S.D.; n = 5, age macheted) and patient 2 at
in SFARI genes. b, Top, sanger sequencing showing a duplication mutation (red two gestational stages. g-h, Bar plots showing normalized GE to cortex volume (g)
arrow) identified in one of the alleles of patient 1. Bottom, sanger sequencing and total brain volume (h) of control (mean ± S.D.; n = 5, age macheted) and patient
showing the mutation was repaired and this cell line is used as an isogenic 2 at two gestational stages.
